175 related articles for article (PubMed ID: 33632085)
41. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.
Lilja-Fischer JK; Eriksen JG; Georgsen JB; Vo TT; Larsen SR; Cheng J; Busch-Sørensen M; Aurora-Garg D; Steiniche T; Overgaard J
Acta Oncol; 2020 Jun; 59(6):666-672. PubMed ID: 32079442
[No Abstract] [Full Text] [Related]
42. PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma.
Wuerdemann N; Gültekin SE; Pütz K; Wittekindt C; Huebbers CU; Sharma SJ; Eckel H; Schubotz AB; Gattenlöhner S; Büttner R; Speel EJ; Klussmann JP; Wagner S; Quaas A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718057
[TBL] [Abstract][Full Text] [Related]
43. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
[TBL] [Abstract][Full Text] [Related]
44. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer.
Tsujiura M; Komatsu S; Ichikawa D; Shiozaki A; Konishi H; Takeshita H; Moriumura R; Nagata H; Kawaguchi T; Hirajima S; Arita T; Fujiwara H; Okamoto K; Otsuji E
Gastric Cancer; 2015 Apr; 18(2):271-9. PubMed ID: 24626859
[TBL] [Abstract][Full Text] [Related]
45. Value of Diffusion-Weighted Magnetic Resonance Imaging Combined with miR-18a Level in Predicting Radiosensitivity of Cervical Cancer.
Bu X; Zhang J; Tian F; Wang X; Wu L; Tian W
Med Sci Monit; 2018 Oct; 24():7271-7278. PubMed ID: 30308669
[TBL] [Abstract][Full Text] [Related]
46. [Predictive markers of immunotherapy in cervical cancer].
Oliushina EM; Zavalishina LE; Andreeva YY; Kuznetsova OA; Moskvina LV; Frank GA
Arkh Patol; 2023; 85(5):5-12. PubMed ID: 37814844
[TBL] [Abstract][Full Text] [Related]
47. Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.
Chen J; Yao D; Li Y; Chen H; He C; Ding N; Lu Y; Ou T; Zhao S; Li L; Long F
Int J Mol Med; 2013 Sep; 32(3):557-67. PubMed ID: 23799609
[TBL] [Abstract][Full Text] [Related]
48. Serum and tissue miRNAs: potential biomarkers for the diagnosis of cervical cancer.
Farzanehpour M; Mozhgani SH; Jalilvand S; Faghihloo E; Akhavan S; Salimi V; Azad TM
Virol J; 2019 Oct; 16(1):116. PubMed ID: 31590680
[TBL] [Abstract][Full Text] [Related]
49. Loss of MHC Class I Expression in HPV-associated Cervical and Vulvar Neoplasia: A Potential Mechanism of Resistance to Checkpoint Inhibition.
Dibbern ME; Bullock TN; Jenkins TM; Duska LR; Stoler MH; Mills AM
Am J Surg Pathol; 2020 Sep; 44(9):1184-1191. PubMed ID: 32496434
[TBL] [Abstract][Full Text] [Related]
50. PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential.
Rotman J; den Otter LAS; Bleeker MCG; Samuels SS; Heeren AM; Roemer MGM; Kenter GG; Zijlmans HJMAA; van Trommel NE; de Gruijl TD; Jordanova ES
Front Immunol; 2020; 11():596825. PubMed ID: 33424844
[TBL] [Abstract][Full Text] [Related]
51. High-Grade Neuroendocrine Carcinoma of the Head and Neck: Human Papillomavirus Status and PD-L1 Expression.
Bahr K; Zimmer S; Springer E; Fottner C; Becker S; Ernst BP; Matthias C; Künzel J
ORL J Otorhinolaryngol Relat Spec; 2019; 81(5-6):309-316. PubMed ID: 31550725
[TBL] [Abstract][Full Text] [Related]
52. Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients.
El-Guindy DM; Helal DS; Sabry NM; Abo El-Nasr M
J Egypt Natl Canc Inst; 2018 Dec; 30(4):125-131. PubMed ID: 30337185
[TBL] [Abstract][Full Text] [Related]
53. IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway.
Cai H; Yan L; Liu N; Xu M; Cai H
Biomed Pharmacother; 2020 Mar; 123():109790. PubMed ID: 31896065
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.
Anastasiadou E; Stroopinsky D; Alimperti S; Jiao AL; Pyzer AR; Cippitelli C; Pepe G; Severa M; Rosenblatt J; Etna MP; Rieger S; Kempkes B; Coccia EM; Sui SJH; Chen CS; Uccini S; Avigan D; Faggioni A; Trivedi P; Slack FJ
Leukemia; 2019 Jan; 33(1):132-147. PubMed ID: 29946193
[TBL] [Abstract][Full Text] [Related]
55. Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition.
Kwon MJ; Rho YS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Kim ES; Park B; Hong M; Min KW
Hum Pathol; 2018 Oct; 80():28-39. PubMed ID: 29634978
[TBL] [Abstract][Full Text] [Related]
56. MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin.
Geng D; Song X; Ning F; Song Q; Yin H
Int J Gynecol Cancer; 2015 May; 25(4):707-13. PubMed ID: 25675046
[TBL] [Abstract][Full Text] [Related]
57. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
[TBL] [Abstract][Full Text] [Related]
58. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
59. Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection.
Zamani S; Sohrabi A; Hosseini SM; Rahnamaye-Farzami M; Akbari A
Microrna; 2019; 8(2):110-115. PubMed ID: 30332981
[TBL] [Abstract][Full Text] [Related]
60. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]